SLR Private Credit BDC II 10-Q 7 Aug 24 2024 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2024	Aug. 05, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity Registrant Name	SLR Private Credit BDC II LLC
Entity Central Index Key	0001932591
Securities Act File Number	814-01616
Entity Tax Identification Number	88-1890628
Entity Incorporation, State or Country Code	DE
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, Address Line One	500 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
Local Phone Number	993-1670
City Area Code	212
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Common Stock, Shares Outstanding		902,038

Consolidated Statement of Asset

Consolidated Statement of Assets and Liabilities - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Investments at fair value:
Non-controlled/non-affiliated investments (cost: $34,574 and $21,560, respectively)	$ 34,889	$ 21,654
Cash	1,022	323
Cash equivalents (cost: $0 and $4,960, respectively)	0	4,960
Interest receivable	223	138
Receivable, Investment, Sale	2	0
Prepaid expenses	23	16
Total assets	36,159	27,091
Liabilities
Payable for cash equivalents purchased	0	4,960
Management fee payable (see note 3)	289	138
Administration fee payable (see note 3)	6	3
Interest payable (see note 5)	265	85
Other liabilities and accrued expenses	512	536
Total liabilities	21,784	18,456
Commitments and contingencies (see note 6)
Unitholders' Capital
Common Unitholders' capital (902,038and 551,497 units, respectively, issued and outstanding)	14,631	9,131
Accumulated distributable net loss	(256)	(496)
Total unitholders' capital	14,375	8,635
Total liabilities and unitholders' capital	$ 36,159	$ 27,091
Net asset value per unit	$ 15.94	$ 15.66
Subscription Facility [Member]
Liabilities
Revolving credit facility	$ 12,905	$ 11,080
SPV Facility [Member]
Liabilities
Revolving credit facility	$ 7,807	$ 1,654

Consolidated Statement of Ass_2

Consolidated Statement of Assets and Liabilities (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Investment owned, at cost	$ 34,574	$ 21,560
Common units issued	902,038	551,497
Units at beginning of period	902,038	551,497
Subscription Facility [Member]
Debt instrument face amount	$ 13,100	$ 11,400
Debt instrument unamortized debt issuance costs, net	195	320
SPV Facility [Member]
Debt instrument face amount	8,200	2,000
Debt instrument unamortized debt issuance costs, net	393	346
US Treasury Securities | Cash Equivalents
Amortized cost of investment in debt security	$ 0	$ 4,960

Consolidated Statements of Oper

Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2024
Investment Income:
Interest income from non-controlled/non-affiliated investments	$ 990	$ 42	$ 43	$ 1,837
Other income from non-controlled/non-affiliated investments	70	0	0	91
Total investment income	1,060	42	43	1,928
Expenses:
Management fees (see note 3)	106	11	11	201
Administration fees (see note 3)	6	0	0	11
Interest and other credit facility expenses (see note 5)	573	124	154	1,083
Organizational expenses	0	15	131	0
Other general and administrative expenses	138	260	428	320
Total expenses	823	410	724	1,615
Net investment income (loss)	237	(368)	(681)	313
Realized and unrealized gain (loss) on investments and cash equivalents:
Net realized loss on non-controlled/non-affiliated investments and cash equivalents	0	0	0	(1)
Net change in unrealized gain (loss) on non-controlled/non-affiliated investments and cash equivalents	100	(1)	(1)	221
Net realized and unrealized gain (loss) on non-controlled/non-affiliated investments and cash equivalents	100	(1)	(1)	220
Net Increase (Decrease) in Unitholders' Capital Resulting From Operations	$ 337	$ (369)	$ (682)	$ 533
Net Income (Loss) Per Unit	$ 0.48	$ (3.08)	$ (5.69)	$ 0.81

Consolidated Statements of Chan

Consolidated Statements of Changes in Unitholders' Capital (Unaudited) - USD ($) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2024
Increase (decrease) in unitholders' capital resulting from operations:
Net investment income (loss)	$ 237	$ (368)	$ (681)	$ 313
Net realized loss	0	0	0	(1)
Net change in unrealized gain (loss)	100	(1)	(1)	221
Net Increase (Decrease) in Unitholders' Capital Resulting From Operations	337	(369)	(682)	533
Distributions to unitholders:
From distributable earnings	(163)	0	0	(293)
Investment Company, Dividend Distribution, Total	163	0	0	293
Increase (decrease) in unitholders' capital resulting from capital activity:
Contributions	4,000	0	3,001	5,500
Less offering costs	0	(1)	(74)	0
Cancellation	0	0	(1)	0
Net increase in unitholders' capital resulting from capital activity	4,000	(1)	2,926	5,500
Total increase in unitholders' capital	4,174	(370)	2,244	5,740
Unitholders' capital, beginning of period	10,201	2,614	0	8,635
Unitholders' capital, end of period	$ 14,375	$ 2,244	$ 2,244	$ 14,375
Capital unit activity (see note 7):
Units issued	254,939	0	120,040	350,541
Units canceled	0	0	(40)	0
Net increase from capital unit activity	254,939	0	120,000	350,541

Consolidated Statement Of Cash

Consolidated Statement Of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended	11 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2024	Dec. 31, 2023
Cash Flows from Operating Activities:
Net increase (decrease) in unitholders' capital resulting from operations	$ 337	$ (369)	$ (682)	$ 533
Adjustments to reconcile net increase (decrease) in unitholders' capital resulting from operations to net cash provided by (used in) operating activities:
Net realized loss on investments and cash equivalents	0	0	0	1
Net change in unrealized gain on investments	(100)	1	1	(221)	$ (94)
Deferred financing costs amortization			79	197
Net accretion of discount on investments			(1)	(75)
(Increase) decrease in operating assets:
Purchase of investments			(1,786)	(16,515)
Proceeds from disposition of investments			2	3,589
Capitalization of payment-in-kind income			0	(14)
Interest receivable			(12)	(85)
Receivable for investments sold			0	(2)
Prepaid expenses			(515)	(7)
Increase (decrease) in operating liabilities:
Payable for cash equivalents purchased			2,984	(4,960)
Management fee payable			11	151
Administration fee payable			0	3
Interest payable			63	180
Other liabilities and accrued expenses			100	(24)
Net Cash Provided by (Used in) Operating Activities			244	(17,249)
Cash Flows from Financing Activities:
Contributions from unitholders			3,001	5,500
Cash distributions paid			0	(293)
Offering costs			(74)	0
Cancellation of units			(1)	0
Proceeds from borrowings			1,671	16,381
Repayments of borrowings			(1,750)	(8,600)
Net Cash Provided by Financing Activities			2,847	12,988
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS			3,091	(4,261)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD			0	5,283	0
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$ 1,022	$ 3,091	3,091	1,022	$ 5,283
Supplemental disclosure of cash flow information:
Cash paid for interest			$ 91	$ 706

Consolidated Schedule of Invest

Consolidated Schedule of Investments (unaudited) - USD ($) $ in Thousands		6 Months Ended		12 Months Ended
		Jun. 30, 2024		Dec. 31, 2023
Schedule of Investments [Line Items]
Cost		$ 34,574		$ 21,560
Fair Value		34,889		21,654
Liabilities in Excess of Other Assets		(20,514)		(17,979)
Net Assets		$ 14,375		$ 8,635
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loan — 250.7% | Medrina, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.67% | 10/20/2023 | 10/20/2029
Schedule of Investments [Line Items]
Industry				Health Care Providers & Services
Spread above Index	[1]			S+625
Floor Rate				1%
Interest Rate	[2]			11.67%
Acquisition Date				Oct. 20, 2023
Maturity Date				Oct. 20, 2029
Par Amount				$ 555
Cost				542
Fair Value				$ 541
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans 250.7% | The Townsend Company, LLC | Commercial Services & Supplies | S+625 | 1.00% | 11.61% | 8/21/2023 | 8/15/2029
Schedule of Investments [Line Items]
Industry	[3]			Commercial Services & Supplies
Spread above Index	[1],[3]			S+625
Floor Rate	[3]			1%
Interest Rate	[2],[3]			11.61%
Acquisition Date	[3]			Aug. 21, 2023
Maturity Date	[3]			Aug. 15, 2029
Par Amount	[3]			$ 805
Cost	[3]			786
Fair Value	[3]			$ 805
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans 250.7% | Toptal, LLC | Commercial Services & Supplies | P+250 | 7.50% | 11.00% | 12/28/2023 | 12/28/2026
Schedule of Investments [Line Items]
Industry				Commercial Services & Supplies
Spread above Index	[1]			P+250
Floor Rate				7.50%
Interest Rate	[2]			11%
Acquisition Date				Dec. 28, 2023
Maturity Date				Dec. 28, 2026
Par Amount				$ 1,562
Cost				1,562
Fair Value				$ 1,562
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | AAH Topco., LLC | Diversified Consumer Services | S+600 | 0.75% | 11.43% | 1/30/2024 | 12/22/2027
Schedule of Investments [Line Items]
Industry	[4]	Diversified Consumer Services
Spread above Index	[4],[5]	S+600
Floor Rate	[4]	0.75%
Interest Rate	[4],[6]	11.43%
Acquisition Date	[4]	Jan. 30, 2024
Maturity Date	[4]	Dec. 22, 2027
Par Amount	[4]	$ 765
Cost	[4]	750
Fair Value	[4]	$ 765
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Accession Risk Management Group, Inc. | Insurance | S+550 | 0.75% | 10.98% | 12/4/2023 | 11/1/2029
Schedule of Investments [Line Items]
Industry	[4]	Insurance
Spread above Index	[4],[5]	S+550
Floor Rate	[4]	0.75%
Interest Rate	[4],[6]	10.98%
Acquisition Date	[4]	Dec. 04, 2023
Maturity Date	[4]	Nov. 01, 2029
Par Amount	[4]	$ 1,595
Cost	[4]	1,589
Fair Value	[4]	$ 1,595
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Alkeme Intermediary Holdings, LLC | Insurance | S+600 | 1.00% | 11.44% | 9/20/2023 | 10/28/2026
Schedule of Investments [Line Items]
Industry	[4]	Insurance
Spread above Index	[4],[5]	S+600
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.44%
Acquisition Date	[4]	Sep. 20, 2023
Maturity Date	[4]	Oct. 28, 2026
Par Amount	[4]	$ 1,332
Cost	[4]	1,298
Fair Value	[4]	$ 1,332
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Apex Service Partners, LLC | Diversified Consumer Services | S+650 | 1.00% | 11.83% | 10/27/2023 | 10/24/2030
Schedule of Investments [Line Items]
Industry	[4]	Diversified Consumer Services
Spread above Index	[4],[5],[7]	S+650
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.83%
Acquisition Date	[4]	Oct. 27, 2023
Maturity Date	[4]	Oct. 24, 2030
Par Amount	[4]	$ 1,344
Cost	[4]	1,313
Fair Value	[4]	$ 1,344
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Ardelyx, Inc. | Pharmaceuticals | S+425 | 4.70% | 9.60% | 3/1/2024 | 3/1/2027
Schedule of Investments [Line Items]
Industry	[4],[8]	Pharmaceuticals
Spread above Index	[4],[5],[8]	S+425
Floor Rate	[4],[8]	4.70%
Interest Rate	[4],[6],[8]	9.60%
Acquisition Date	[4],[8]	Mar. 01, 2024
Maturity Date	[4],[8]	Mar. 01, 2027
Par Amount	[4],[8]	$ 750
Cost	[4],[8]	751
Fair Value	[4],[8]	$ 754
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | CVAUSA Management, LLC | Health Care Providers & Services | S+650 | 1.00% | 11.75% | 5/22/2023 | 5/22/2029
Schedule of Investments [Line Items]
Industry	[4]	Health Care Providers & Services
Spread above Index	[4],[5]	S+650
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.75%
Acquisition Date	[4]	May 22, 2023
Maturity Date	[4]	May 22, 2029
Par Amount	[4]	$ 1,178
Cost	[4]	1,147
Fair Value	[4]	$ 1,178
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Cerapedics, Inc. | Biotechnology | S+620 | 2.75% | 11.53% | 10/3/2023 | 1/1/2028
Schedule of Investments [Line Items]
Industry	[4]	Biotechnology
Spread above Index	[4],[5]	S+620
Floor Rate	[4]	2.75%
Interest Rate	[4],[6]	11.53%
Acquisition Date	[4]	Oct. 03, 2023
Maturity Date	[4]	Jan. 01, 2028
Par Amount	[4]	$ 851
Cost	[4]	855
Fair Value	[4]	$ 855
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Crewline Buyer, Inc. | IT Services | S+675 | 1.00% | 12.08% | 11/8/2023 | 11/8/2030
Schedule of Investments [Line Items]
Industry	[4]	IT Services
Spread above Index	[4],[5]	S+675
Floor Rate	[4]	1%
Interest Rate	[4],[6]	12.08%
Acquisition Date	[4]	Nov. 08, 2023
Maturity Date	[4]	Nov. 08, 2030
Par Amount	[4]	$ 1,171
Cost	[4]	1,144
Fair Value	[4]	$ 1,171
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Exactcare Parent, Inc. | Health Care Providers & Services | S+650 | 1.00% | 11.84% | 11/3/2023 | 11/5/2029
Schedule of Investments [Line Items]
Industry	[4]	Health Care Providers & Services
Spread above Index	[4],[5]	S+650
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.84%
Acquisition Date	[4]	Nov. 03, 2023
Maturity Date	[4]	Nov. 05, 2029
Par Amount	[4]	$ 742
Cost	[4]	723
Fair Value	[4]	$ 742
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Eyesouth Eye Care Holdco LLC | Health Care Providers & Services | S+550 | 1.00% | 10.93% | 4/1/2024 | 10/5/2029
Schedule of Investments [Line Items]
Industry	[4]	Health Care Providers & Services
Spread above Index	[4],[5]	S+550
Floor Rate	[4]	1%
Interest Rate	[4],[6]	10.93%
Acquisition Date	[4]	Apr. 01, 2024
Maturity Date	[4]	Oct. 05, 2029
Par Amount	[4]	$ 613
Cost	[4]	601
Fair Value	[4]	$ 600
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Higginbotham Insurance Agency, Inc. | Insurance | S+550 | 1.00% | 10.94% | 8/24/2023 | 11/25/2028
Schedule of Investments [Line Items]
Industry	[4]	Insurance
Spread above Index	[4],[5]	S+550
Floor Rate	[4]	1%
Interest Rate	[4],[6]	10.94%
Acquisition Date	[4]	Aug. 24, 2023
Maturity Date	[4]	Nov. 25, 2028
Par Amount	[4]	$ 1,732
Cost	[4]	1,732
Fair Value	[4]	$ 1,732
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Integrity Marketing Acquisition, LLC | Insurance | S+605 | 0.87% | 11.47% | 6/6/2024 | 8/27/2026
Schedule of Investments [Line Items]
Industry		Insurance
Spread above Index	[5]	S+605
Floor Rate		0.87%
Interest Rate	[6]	11.47%
Acquisition Date		Jun. 06, 2024
Maturity Date		Aug. 27, 2026
Par Amount		$ 1,002
Cost		1,002
Fair Value		$ 1,002
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Legacy Service Partners, LLC | Diversified Consumer Services | S+575 | 1.00% | 11.23% | 3/18/2024 | 1/9/2029
Schedule of Investments [Line Items]
Industry		Diversified Consumer Services
Spread above Index	[5]	S+575
Floor Rate		1%
Interest Rate	[6]	11.23%
Acquisition Date		Mar. 18, 2024
Maturity Date		Jan. 09, 2029
Par Amount		$ 449
Cost		438
Fair Value		$ 449
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | MRI Software, LLC | Software | S+550 | 1.00% | 10.93% | 12/19/2023 | 2/10/2027
Schedule of Investments [Line Items]
Industry	[4]	Software
Spread above Index	[4],[5]	S+550
Floor Rate	[4]	1%
Interest Rate	[4],[6]	10.93%
Acquisition Date	[4]	Dec. 19, 2023
Maturity Date	[4]	Feb. 10, 2027
Par Amount	[4]	$ 1,583
Cost	[4]	1,581
Fair Value	[4]	$ 1,580
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Medrina, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.55% | 10/20/2023 | 10/20/2029
Schedule of Investments [Line Items]
Industry	[4]	Health Care Providers & Services
Spread above Index	[4],[5]	S+625
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.55%
Acquisition Date	[4]	Oct. 20, 2023
Maturity Date	[4]	Oct. 20, 2029
Par Amount	[4]	$ 553
Cost	[4]	540
Fair Value	[4]	$ 553
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | OIS Management Services, LLC | Health Care Providers & Services | S+575 | 0.75% | 11.16% | 12/29/2023 | 11/16/2028
Schedule of Investments [Line Items]
Industry	[4]	Health Care Providers & Services
Spread above Index	[4],[5]	S+575
Floor Rate	[4]	0.75%
Interest Rate	[4],[6]	11.16%
Acquisition Date	[4]	Dec. 29, 2023
Maturity Date	[4]	Nov. 16, 2028
Par Amount	[4]	$ 892
Cost	[4]	883
Fair Value	[4]	$ 874
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | ONS MSO, LLC | Health Care Providers & Services | S+575 | 1.00% | 11.10% | 4/26/2024 | 7/8/2026
Schedule of Investments [Line Items]
Industry	[4]	Health Care Providers & Services
Spread above Index	[4],[5]	S+575
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.10%
Acquisition Date	[4]	Apr. 26, 2024
Maturity Date	[4]	Jul. 08, 2026
Par Amount	[4]	$ 1,509
Cost	[4]	1,495
Fair Value	[4]	$ 1,494
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Outset Medical, Inc. | Health Care Providers & Services | S+515 | 2.75% | 10.48% | 1/2/2024 | 11/1/2027
Schedule of Investments [Line Items]
Industry	[4]	Health Care Equipment & Supplies
Spread above Index	[4],[5]	S+515
Floor Rate	[4]	2.75%
Interest Rate	[4],[6]	10.48%
Acquisition Date	[4]	Jan. 02, 2024
Maturity Date	[4]	Nov. 01, 2027
Par Amount	[4]	$ 3,113
Cost	[4]	3,111
Fair Value	[4]	$ 3,121
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Peter C. Foy & Associates Insurance Services, LLC | Insurance | S+650 | 0.75% | 11.84% | 7/19/2023 | 11/1/2028
Schedule of Investments [Line Items]
Industry	[4]	Insurance
Spread above Index	[4],[5]	S+650
Floor Rate	[4]	0.75%
Interest Rate	[4],[6]	11.84%
Acquisition Date	[4]	Jul. 19, 2023
Maturity Date	[4]	Nov. 01, 2028
Par Amount	[4]	$ 375
Cost	[4]	368
Fair Value	[4]	$ 375
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Quantcast Corporation | Commercial Services & Supplies | S+525 | 2.00% | 10.60% | 6/14/2024 | 6/14/2029
Schedule of Investments [Line Items]
Industry	[4]	Commercial Services & Supplies
Spread above Index	[4],[5]	S+525
Floor Rate	[4]	2%
Interest Rate	[4],[6]	10.60%
Acquisition Date	[4]	Jun. 14, 2024
Maturity Date	[4]	Jun. 14, 2029
Par Amount	[4]	$ 601
Cost	[4]	594
Fair Value	[4]	$ 594
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Retina Midco, Inc. | Health Care Providers & Services | S+515 | 1.00% | 11.34% | 12/18/2023 | 1/31/2026
Schedule of Investments [Line Items]
Industry	[4]	Health Care Providers & Services
Spread above Index	[4],[5]	S+575
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.34%
Acquisition Date	[4]	Dec. 18, 2023
Maturity Date	[4]	Jan. 31, 2026
Par Amount	[4]	$ 3,065
Cost	[4]	3,015
Fair Value	[4]	$ 3,065
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | SPR Therapeutics, Inc. | Health Care Providers & Services | S+515 | 4.00% | 10.48% | 1/30/2024 | 2/1/2029
Schedule of Investments [Line Items]
Industry	[4]	Health Care Technology
Spread above Index	[4],[5]	S+515
Floor Rate	[4]	4%
Interest Rate	[4],[6]	10.48%
Acquisition Date	[4]	Jan. 30, 2024
Maturity Date	[4]	Feb. 01, 2029
Par Amount	[4]	$ 399
Cost	[4]	397
Fair Value	[4]	$ 409
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+550 | 1.00% | 10.83% | 5/17/2024 | 7/27/2026
Schedule of Investments [Line Items]
Industry		Health Care Providers & Services
Spread above Index	[5]	S+550
Floor Rate		1%
Interest Rate	[6]	10.83%
Acquisition Date		May 17, 2024
Maturity Date		Jul. 27, 2026
Par Amount		$ 318
Cost		315
Fair Value		$ 315
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | The Townsend Company, LLC | Commercial Services & Supplies | S+625 | 1.00% | 11.59% | 8/21/2023 | 8/15/2029
Schedule of Investments [Line Items]
Industry	[4]	Commercial Services & Supplies
Spread above Index	[4],[5]	S+625
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.59%
Acquisition Date	[4]	Aug. 21, 2023
Maturity Date	[4]	Aug. 15, 2029
Par Amount	[4]	$ 786
Cost	[4]	769
Fair Value	[4]	786
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Total Bank Debt/Senior Secured Loans
Schedule of Investments [Line Items]
Cost		34,571
Fair Value		$ 34,886
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | UVP Management, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.73% | 9/18/2023 | 9/15/2025
Schedule of Investments [Line Items]
Industry	[4]	Health Care Providers & Services
Spread above Index	[4],[5]	S+625
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.73%
Acquisition Date	[4]	Sep. 18, 2023
Maturity Date	[4]	Sep. 15, 2025
Par Amount	[4]	$ 1,125
Cost	[4]	1,106
Fair Value	[4]	$ 1,091
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Ultimate Baked Goods Midco LLC | Packaged Foods & Meats | S+550 | 1.00% | 10.94% | 6/13/2024 | 8/13/2027
Schedule of Investments [Line Items]
Industry	[4]	Packaged Foods & Meats
Spread above Index	[4],[5]	S+550
Floor Rate	[4]	1%
Interest Rate	[4],[6]	10.94%
Acquisition Date	[4]	Jun. 13, 2024
Maturity Date	[4]	Aug. 13, 2027
Par Amount	[4]	$ 1,950
Cost	[4]	1,940
Fair Value	[4]	$ 1,940
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | United Digestive MSO Parent, LLC | Health Care Providers & Services | S+650 | 1.00% | 11.80% | 3/30/2023 | 3/30/2029
Schedule of Investments [Line Items]
Industry	[4]	Health Care Providers & Services
Spread above Index	[4],[5]	S+650
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.80%
Acquisition Date	[4]	Mar. 30, 2023
Maturity Date	[4]	Mar. 30, 2029
Par Amount	[4]	$ 720
Cost	[4]	702
Fair Value	[4]	$ 720
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Vertos Medical, Inc. | Health Care Equipment & Supplies | S+515 | 4.75% | 10.48% | 6/14/2023 | 7/1/2028
Schedule of Investments [Line Items]
Industry	[4]	Health Care Equipment & Supplies
Spread above Index	[4],[5]	S+515
Floor Rate	[4]	4.75%
Interest Rate	[4],[6]	10.48%
Acquisition Date	[4]	Jun. 14, 2023
Maturity Date	[4]	Jul. 01, 2028
Par Amount	[4]	$ 397
Cost	[4]	396
Fair Value	[4]	$ 399
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | WCI-BXC Purchaser, LLC | Distributors | S+625 | 0.75% | 11.59% | 11/6/2023 | 11/6/2030
Schedule of Investments [Line Items]
Industry	[4]	Distributors
Spread above Index	[4],[5]	S+625
Floor Rate	[4]	0.75%
Interest Rate	[4],[6]	11.59%
Acquisition Date	[4]	Nov. 06, 2023
Maturity Date	[4]	Nov. 06, 2030
Par Amount	[4]	$ 666
Cost	[4]	650
Fair Value	[4]	$ 666
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | West-NR Parent, Inc. | Insurance | S+625 | 1.00% | 11.68% | 8/1/2023 | 12/27/2027
Schedule of Investments [Line Items]
Industry	[4]	Insurance
Spread above Index	[4],[5]	S+625
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.68%
Acquisition Date	[4]	Aug. 01, 2023
Maturity Date	[4]	Dec. 27, 2027
Par Amount	[4]	$ 912
Cost	[4]	896
Fair Value	[4]	$ 912
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | Western Veterinary Partners LLC | Diversified Consumer Services | S+600 | 1.00% | 11.60% | 1/19/2024 | 10/29/2026
Schedule of Investments [Line Items]
Industry	[4]	Diversified Consumer Services
Spread above Index	[4],[5]	S+600
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.60%
Acquisition Date	[4]	Jan. 19, 2024
Maturity Date	[4]	Oct. 29, 2026
Par Amount	[4]	$ 1,310
Cost	[4]	1,292
Fair Value	[4]	$ 1,290
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 242.7% | World Insurance Associates, LLC | Insurance | S+600 | 1.00% | 11.33% | 10/20/2023 | 4/3/2028
Schedule of Investments [Line Items]
Industry	[4]	Insurance
Spread above Index	[4],[5]	S+600
Floor Rate	[4]	1%
Interest Rate	[4],[6]	11.33%
Acquisition Date	[4]	Oct. 20, 2023
Maturity Date	[4]	Apr. 03, 2028
Par Amount	[4]	$ 1,183
Cost	[4]	1,178
Fair Value	[4]	1,183
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% Peter C. Foy & Associates Insurance Services, LLC Industry Insurance Spread above Index S+650 Floor 0.75% Interest Rate 11.86% Acquisition Date 7/19/2023 Maturity Date 11/1/2028
Schedule of Investments [Line Items]
Industry				Insurance
Spread above Index	[1]			S+650
Floor Rate				0.75%
Interest Rate	[2]			11.86%
Acquisition Date				Jul. 19, 2023
Maturity Date				Nov. 01, 2028
Par Amount				$ 377
Cost				370
Fair Value				$ 370
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% Retina Midco, Inc. Industry Health Care Providers & Services Spread above Index S+575 Floor 1.00% Interest Rate 11.38% Acquisition Date 12/18/2023 Maturity Date 1/31/2026
Schedule of Investments [Line Items]
Industry	[3]			Health Care Providers & Services
Spread above Index	[1],[3]			S+575
Floor Rate	[3]			1%
Interest Rate	[2],[3]			11.38%
Acquisition Date	[3]			Dec. 18, 2023
Maturity Date	[3]			Jan. 31, 2026
Par Amount	[3]			$ 2,308
Cost	[3]			2,262
Fair Value	[3]			$ 2,261
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | Accession Risk Management Group, Inc. | Insurance | S+550 | 0.75% | 11.00% | 12/4/2023 | 11/1/2029
Schedule of Investments [Line Items]
Industry				Insurance
Spread above Index	[1]			S+550
Floor Rate				0.75%
Interest Rate	[2]			11%
Acquisition Date				Dec. 04, 2023
Maturity Date				Nov. 01, 2029
Par Amount				$ 1,603
Cost				1,597
Fair Value				$ 1,597
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | Alkeme Intermediary Holdings, LLC | Insurance | S+650 | 1.00% | 11.96% | 9/20/2023 | 10/28/2026
Schedule of Investments [Line Items]
Industry	[3]			Insurance
Spread above Index	[1],[3]			S+650
Floor Rate	[3]			1%
Interest Rate	[2],[3]			11.96%
Acquisition Date	[3]			Sep. 20, 2023
Maturity Date	[3]			Oct. 28, 2026
Par Amount	[3]			$ 667
Cost	[3]			649
Fair Value	[3]			$ 667
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | CVAUSA Management, LLC | Health Care Providers & Services | S+650 | 1.00% | 11.74% | 5/22/2023 | 5/22/2029
Schedule of Investments [Line Items]
Industry				Health Care Providers & Services
Spread above Index	[1]			S+650
Floor Rate				1%
Interest Rate	[2]			11.74%
Acquisition Date				May 22, 2023
Maturity Date				May 22, 2029
Par Amount				$ 1,184
Cost				1,150
Fair Value				$ 1,184
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | Crewline Buyer, Inc. | IT Services | S+675 | 1.00% | 12.10% | 11/8/2023 | 11/8/2030
Schedule of Investments [Line Items]
Industry				IT Services
Spread above Index	[1]			S+675
Floor Rate				1%
Interest Rate	[2]			12.10%
Acquisition Date				Nov. 08, 2023
Maturity Date				Nov. 08, 2030
Par Amount				$ 1,171
Cost				1,142
Fair Value				$ 1,142
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | Exactcare Parent, Inc. | Health Care Providers & Services | S+650 | 1.00% | 11.89% | 11/3/2023 | 11/5/2029
Schedule of Investments [Line Items]
Industry				Health Care Providers & Services
Spread above Index	[1]			S+650
Floor Rate				1%
Interest Rate	[2]			11.89%
Acquisition Date				Nov. 03, 2023
Maturity Date				Nov. 05, 2029
Par Amount				$ 744
Cost				724
Fair Value				$ 723
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | Higginbotham Insurance Agency, Inc. | Insurance | S+550 | 1.00% | 10.96% | 8/24/2023 | 11/25/2028
Schedule of Investments [Line Items]
Industry				Insurance
Spread above Index	[1]			S+550
Floor Rate				1%
Interest Rate	[2]			10.96%
Acquisition Date				Aug. 24, 2023
Maturity Date				Nov. 25, 2028
Par Amount				$ 1,740
Cost				1,740
Fair Value				$ 1,740
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | MRI Software, LLC | Software | S+550 | 1.00% | 10.95% | 12/19/2023 | 2/10/2027
Schedule of Investments [Line Items]
Industry	[3]			Software
Spread above Index	[1],[3]			S+550
Floor Rate	[3]			1%
Interest Rate	[2],[3]			10.95%
Acquisition Date	[3]			Dec. 19, 2023
Maturity Date	[3]			Feb. 10, 2027
Par Amount	[3]			$ 1,591
Cost	[3]			1,589
Fair Value	[3]			$ 1,589
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | OIS Management Services, LLC | Health Care Providers & Services | S+575 | 1.00% | 11.20% | 12/29/2023 | 11/16/2028
Schedule of Investments [Line Items]
Industry	[3]			Health Care Providers & Services
Spread above Index	[1],[3]			S+575
Floor Rate	[3]			0.75%
Interest Rate	[2],[3]			11.20%
Acquisition Date	[3]			Dec. 29, 2023
Maturity Date	[3]			Nov. 16, 2028
Par Amount	[3]			$ 697
Cost	[3]			691
Fair Value	[3]			683
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | Total Bank Debt/Senior Secured Loans
Schedule of Investments [Line Items]
Cost				21,557
Fair Value				$ 21,651
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | UVP Management, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.75% | 9/18/2023 | 9/15/2025
Schedule of Investments [Line Items]
Industry				Health Care Providers & Services
Spread above Index	[1]			S+625
Floor Rate				1%
Interest Rate	[2]			11.75%
Acquisition Date				Sep. 18, 2023
Maturity Date				Sep. 15, 2025
Par Amount				$ 1,023
Cost				1,001
Fair Value				$ 998
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | United Digestive MSO Parent, LLC | Health Care Providers & Services | S+675 | 1.00% | 12.25% | 3/30/2023 | 3/30/2029
Schedule of Investments [Line Items]
Industry				Health Care Providers & Services
Spread above Index	[1]			S+675
Floor Rate				1%
Interest Rate	[2]			12.25%
Acquisition Date				Mar. 30, 2023
Maturity Date				Mar. 30, 2029
Par Amount				$ 687
Cost				669
Fair Value				$ 687
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | Vertos Medical, Inc | Health Care Equipment & Supplies | S+515 | 4.75% | 10.50% | 6/14/2023 | 7/1/2028
Schedule of Investments [Line Items]
Industry	[3]			Health Care Equipment & Supplies
Spread above Index	[1],[3]			S+515
Floor Rate	[3]			4.75%
Interest Rate	[2],[3]			10.50%
Acquisition Date	[3]			Jun. 14, 2023
Maturity Date	[3]			Jul. 01, 2028
Par Amount	[3]			$ 397
Cost	[3]			394
Fair Value	[3]			$ 397
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | WCI-BXC Purchaser, LLC | Distributors | S+625 | 1.00% | 11.64% | 11/6/2023 | 11/6/2030
Schedule of Investments [Line Items]
Industry				Distributors
Spread above Index	[1]			S+625
Floor Rate				1%
Interest Rate	[2]			11.64%
Acquisition Date				Nov. 06, 2023
Maturity Date				Nov. 06, 2030
Par Amount				$ 669
Cost				653
Fair Value				$ 653
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | West-NR Parent, Inc. | Insurance | S+625 | 1.00% | 11.70% | 8/1/2023 | 12/27/2027
Schedule of Investments [Line Items]
Industry				Insurance
Spread above Index	[1]			S+625
Floor Rate				1%
Interest Rate	[2]			11.70%
Acquisition Date				Aug. 01, 2023
Maturity Date				Dec. 27, 2027
Par Amount				$ 916
Cost				899
Fair Value				$ 916
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7% | World Insurance Associates, LLC | Insurance | S+600 | 1.00% | 11.35% | 10/20/2023 | 4/3/2028
Schedule of Investments [Line Items]
Industry				Insurance
Spread above Index	[1]			S+600
Floor Rate				1%
Interest Rate	[2]			11.35%
Acquisition Date				Oct. 20, 2023
Maturity Date				Apr. 03, 2028
Par Amount				$ 1,189
Cost				1,183
Fair Value				$ 1,183
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7%| Apex Service Partners, LLC | Diversified Consumer Services | S+650 | 1.00% | 11.87% | 10/27/2023 | 10/24/2030
Schedule of Investments [Line Items]
Industry	[9]			Diversified Consumer Services
Spread above Index	[1],[9]			S+650
Floor Rate	[9]			1%
Interest Rate	[2],[9]			11.87%
Acquisition Date	[9]			Oct. 27, 2023
Maturity Date	[9]			Oct. 24, 2030
Par Amount	[9]			$ 1,130
Cost	[9]			1,102
Fair Value	[9]			$ 1,102
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 250.7%| Cerapedics, Inc. | Biotechnology | S+620 | 2.75% | 11.55% | 10/3/2023 | 1/1/2028
Schedule of Investments [Line Items]
Industry	[3]			Biotechnology
Spread above Index	[1],[3]			S+620
Floor Rate	[3]			2.75%
Interest Rate	[2],[3]			11.55%
Acquisition Date	[3]			Oct. 03, 2023
Maturity Date	[3]			Jan. 01, 2028
Par Amount	[3]			$ 851
Cost	[3]			852
Fair Value	[3]			$ 851
Investment, Identifier [Axis]: Cash Equivalents | US Treasury Bill | Government | 12/29/2023 | 2/27/2024
Schedule of Investments [Line Items]
Industry	[10]			Government
Acquisition Date				Dec. 29, 2023
Maturity Date				Feb. 27, 2024
Par Amount				$ 5,000
Cost				4,960
Fair Value				4,960
Investment, Identifier [Axis]: Total Investments
Schedule of Investments [Line Items]
Cost		34,574	[11]	21,560	[12]
Fair Value		34,889	[11]	21,654	[12]
Investment, Identifier [Axis]: Total Investments & Cash Equivalents
Schedule of Investments [Line Items]
Cost				26,520
Fair Value				26,614
Investment, Identifier [Axis]: Warrants | Total Warrants
Schedule of Investments [Line Items]
Cost		3		3
Fair Value		$ 3		$ 3
Investment, Identifier [Axis]: Warrants | Vertos Medical Inc | Health Care Equipment & Supplies | 6/14/2023
Schedule of Investments [Line Items]
Industry	[10]			Health Care Equipment & Supplies
Acquisition Date	[10]			Jun. 14, 2023
Par Amount	[10]			$ 9,646
Cost	[10]			3
Fair Value	[10]			$ 3
Investment, Identifier [Axis]: Warrants | Vertos Medical, Inc. | Health Care Equipment & Supplies | 6/14/2023
Schedule of Investments [Line Items]
Industry	[13]	Health Care Equipment & Supplies
Acquisition Date	[13]	Jun. 14, 2023
Par Amount	[13]	$ 9,646
Cost	[13]	3
Fair Value	[13]	$ 3
[1] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor. Floating rate debt investments typically bear interest at a rate determined by reference to either the Secured Overnight Financing Rate or the prime index rate, and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2023. Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SLR Private Credit BDC II SPV LLC. Such investments are pledged as collateral under the SPV Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SLR Private Credit BDC II SPV LLC (the “SPV”). Such investments are pledged as collateral under the SPV Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor. Floating rate debt investments typically bear interest at a rate determined by reference to either the Secured Overnight Financing Rate (“SOFR”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, the Company has provided the current interest rate in effect as of June 30, 2024. S+ 650 spread on revolver tranche, S+ 500 plus 2.00 % payment-in-kind (“PIK”) on term loan tranche. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (the “1940 Act”) . If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of June 30, 2024, on a fair value basis, non-qualifying assets in our portfolio represented 2.1 % of the total assets of the Company. S+ 650 spread on revolver tranche, S+ 500 plus 2.00 % PIK on term loan tranche. Non-income producing security. Aggregate net unrealized depreciation for U.S. federal income tax purposes is $ 153 ; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $ 343 and $ 496 , respectively, based on a tax cost of $ 35,042 . The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. Aggregate net unrealized depreciation for U.S. federal income tax purposes is $ 374 ; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $ 110 and $ 484 , respectively, based on a tax cost of $ 22,028 . The Company generally acquires its investments in private transactions exempt from registration under the Securities Act. These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. Non-income producing security

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments 1	Jun. 30, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
Percentage of Total Investments	100%	100%
Bank Debt And Senior Secured Loans
Schedule of Investments [Line Items]
Percentage of Total Investments	242.70%	250.70%
Bank Debt And Senior Secured Loans | Health Care Providers And Services
Schedule of Investments [Line Items]
Percentage of Total Investments	30.50%	32.70%
Bank Debt And Senior Secured Loans | Insurance
Schedule of Investments [Line Items]
Percentage of Total Investments	23.30%	29.90%
Bank Debt And Senior Secured Loans | Diversified Consumer Services
Schedule of Investments [Line Items]
Percentage of Total Investments	11%	5.10%
Bank Debt And Senior Secured Loans | Health Care Equipment And Supplies
Schedule of Investments [Line Items]
Percentage of Total Investments	10.10%	1.90%
Bank Debt And Senior Secured Loans | Packaged Foods & Meats
Schedule of Investments [Line Items]
Percentage of Total Investments	5.50%
Bank Debt And Senior Secured Loans | Commercial Services & Supplies
Schedule of Investments [Line Items]
Percentage of Total Investments	4%	10.90%
Bank Debt And Senior Secured Loans | Software
Schedule of Investments [Line Items]
Percentage of Total Investments	4.50%	7.30%
Bank Debt And Senior Secured Loans | IT Services
Schedule of Investments [Line Items]
Percentage of Total Investments	3.40%	5.30%
Bank Debt And Senior Secured Loans | Biotechnology
Schedule of Investments [Line Items]
Percentage of Total Investments	2.40%	3.90%
Bank Debt And Senior Secured Loans | Pharmaceuticals
Schedule of Investments [Line Items]
Percentage of Total Investments	2.20%
Bank Debt And Senior Secured Loans | Distributors
Schedule of Investments [Line Items]
Percentage of Total Investments	1.90%	3%
Bank Debt And Senior Secured Loans | Health Care Technology
Schedule of Investments [Line Items]
Percentage of Total Investments	1.20%

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments (unaudited) (Parenthetical) - USD ($) $ in Thousands	6 Months Ended		12 Months Ended
	Jun. 30, 2024		Dec. 31, 2023
Summary of Investment Holdings [Line Items]
Tax basis of investments gross unrealized depreciation	$ 496		$ 484
Tax basis of investments gross unrealized appreciation	343		110
Tax basis of investments cost for income tax purpose	$ 35,042		22,028
Percentage of non qualifying assets in the portfolio of total assets	2.10%
Tax basis of investments unrealized appreciation depreciation net	$ 153		$ 374
Percentage of Total Investments	100%		100%
Warrants [Member]
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	0%		0.10%
Total Investments
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	242.70%	[1]	250.80%	[2]
Cash Equivalents
Summary of Investment Holdings [Line Items]
Percentage of Total Investments			57.40%
Total Investments and Cash Equivalents
Summary of Investment Holdings [Line Items]
Percentage of Total Investments			308.20%
Liabilities In Excess Of Other Assets
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	142.70%	[1]	208.20%
Net Assets
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	100%		100%
Revolver Tranche
Summary of Investment Holdings [Line Items]
Investment, Basis Spread, Variable Rate	650%		650%
Term Loan Tranche [Member]
Summary of Investment Holdings [Line Items]
Investment, Basis Spread, Variable Rate	500%		500%
Percentage spread as paid in kind	2%		2%
Bank Debt And Senior Secured Loans
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	242.70%		250.70%
Bank Debt And Senior Secured Loans | Health Care Providers And Services
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	30.50%		32.70%
Bank Debt And Senior Secured Loans | Insurance
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	23.30%		29.90%
Bank Debt And Senior Secured Loans | Commercial Services & Supplies
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	4%		10.90%
Bank Debt And Senior Secured Loans | Software
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	4.50%		7.30%
Bank Debt And Senior Secured Loans | IT Services [Member]
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	3.40%		5.30%
Bank Debt And Senior Secured Loans | Diversified Consumer Services [Member]
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	11%		5.10%
Bank Debt And Senior Secured Loans | Biotechnology [Member]
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	2.40%		3.90%
Bank Debt And Senior Secured Loans | Health Care Equipment And Supplies
Summary of Investment Holdings [Line Items]
Percentage of Total Investments	10.10%		1.90%
U.S. Treasury Bill
Summary of Investment Holdings [Line Items]
Percentage of Total Investments			5.33%
[1] Aggregate net unrealized depreciation for U.S. federal income tax purposes is $ 153 ; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $ 343 and $ 496 , respectively, based on a tax cost of $ 35,042 . The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. Aggregate net unrealized depreciation for U.S. federal income tax purposes is $ 374 ; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $ 110 and $ 484 , respectively, based on a tax cost of $ 22,028 . The Company generally acquires its investments in private transactions exempt from registration under the Securities Act. These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2024
Pay vs Performance Disclosure
Net Income (Loss)	$ 337	$ (369)	$ (682)	$ 533

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
NonRule 10b5-1 Arrangement Modified	false

N-2

N-2 - $ / shares	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023	Jan. 17, 2023
Cover [Abstract]
Entity Central Index Key	0001932591
Amendment Flag	false
Securities Act File Number	814-01616
Document Type	10-Q
Entity Registrant Name	SLR Private Credit BDC II LLC
Entity Address, Address Line One	500 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	993-1670
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
General Description of Registrant [Abstract]
Investment Objectives and Practices [Text Block]	Portfolio and Investment Activity During the three months ended June 30, 2024, we invested $9.8 million across 15 portfolio companies. This compares to investing $1.1 million across 2 portfolio companies during the three months ended June 30, 2023. Investments sold or prepaid during the three months ended June 30, 2024 totaled $2.1 million. Investments sold or prepaid during the three months ended June 30, 2023 were de minimis. At June 30, 2024, our portfolio consisted of 32 portfolio companies and was invested more than 99.9% directly in senior secured loans and less than 0.1% in warrants, versus 3 portfolio company invested 99.8% directly in senior secured loans and 0.2% in warrants at June 30, 2023, in each case measured at fair value. At June 30, 2024 and June 30, 2023, 100% of our income producing investment portfolio was floating rate, measured at fair value.
Risk Factors [Table Text Block]	Item 1A. Risk Factors In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the February 27, 2024 filing of our Annual Report on Form 10-K, which could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. There have been no material changes during the six months ended June 30, 2024 to the risk factors discussed in “Risk Factors” in the February 27, 2024 filing of our Annual Report on Form 10-K.
NAV Per Share	$ 15.94	$ 15.66	$ 18.7	$ 0

Organization

Organization	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Note 1. Organization SLR Private Credit BDC II LLC (the “Company”, “we”, “us” or “our”) was formed as a limited liability company under the laws of the State of Delaware on April 18, 2022 as an externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it applies the guidance in the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company intends to elect to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). As a BDC and a RIC, we are required to comply with certain regulatory requirements. The Company was formed primarily to provide investors with attractive long-term returns through investments made pursuant to the investment strategy of the Company described below. SLR Capital Partners, LLC (the “Adviser” or “SLR”) serves as the Company’s investment adviser pursuant to an investment management agreement with the Company (as amended, restated or otherwise modified from time to time, the “Investment Management Agreement”). The fiscal year end of the Company is December 31. In connection with the Company’s formation, the Company issued and sold 40 of the Company’s units (“Units”) to the Adviser (the “Initial Unitholder”), which were acquired for an initial capital contribution of $1 on January 18, 2023 in reliance upon the available exemptions from registration requirements of Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). As of June 30, 2024, the Company has closed on $ 66,780 in capital commitments. The Company’s initial drawdown occurred on March 31, 2023 with the sale and issuance of Units at an aggregate purchase price of $ 3,000 or $ 25.00 per Unit. Prior to the issuance of Units on March 31, 2023, the Initial Unitholder’s initial seed capital was withdrawn from the Company and its Units were canceled. As of June 30, 2024, $ 15,400 of capital commitments were drawn and $ 51,380 were unfunded. To seek to achieve its investment objective, the Company expects to invest in directly originated cash flow loans issued to sponsor-owned upper-middle-market companies and in niche specialty finance loans with attractive risk-return characteristics. Borrowers in the Company’s cash flow strategy are expected to typically generate $ 25,000 to $ 250,000 or more of EBITDA (defined below), operate in non-cyclical industries, demonstrate defensive business models, and be owned by leading private equity firms. The Company’s specialty finance investments will encompass asset-based lending to asset-rich companies in a variety of industries. The Company’s investments in portfolio companies are referred to herein as “Portfolio Investments”. The offering period of the Company is currently expected to be for a period of approximately eighteen months from August 9, 2023 (the “Offering Period”). The Company is expected to conduct its offering pursuant to which investors will make equity capital commitments (“Commitments”) pursuant to a subscription agreement entered into with the Company where the investor will agree to purchase an interest in the Company for an aggregate purchase price equal to its Commitment. Each investor will purchase Units each time the Company delivers a drawdown notice, typically ten business days prior to a required funding date. The offering and sale of the Units is expected to be exempt from registration pursuant to Regulation D and Regulation S promulgated under the Securities Act, for offers and sales of securities that do not involve a public offering and for offers and sales of securities outside of the United States, respectively. The term of the Company is expected to be seven years from the end of the Offering Period (unless terminated earlier or the Company effectuates an Exchange Listing (defined below) as set forth in the Limited Liability Company Agreement of the Company (as amended, restated or otherwise modified from time to time, the “LLC Agreement”)), but may be extended by the Company’s board of directors (the “Board”) for up to two consecutive one-year periods upon approval of the Company’s independent directors and the approval of unitholders of the Company (“Unitholders”), which approval will be obtained through a non-1940 Act vote as described in Item 11 of the Company’s Form 10. The Company may be dissolved and its affairs wound up prior to the end of the term under the circumstances set forth in the LLC Agreement. At any time prior to the end of the term, subject to any requirements of the 1940 Act and applicable law, the Board may, without the approval of the Unitholders, cause the Company (or any successor entity to the Company) to be merged with and into an affiliated entity that is regulated under the 1940 Act, whose securities are listed for trading on a national securities exchange, and that will have a total net asset value of at least $ 1,000,000 immediately after the closing of such merger, subject to any limitations under the 1940 Act (an “Exchange Listing”). In connection with, and prior to, any such Exchange Listing, subject to any requirements of the 1940 Act and applicable law, the Board may, without the approval of Unitholders, cause the Company to complete (i) the sale, exchange or disposition of all or a portion of the assets of the Company, or (ii) a conversion of the Company into a corporation incorporated in a state determined by the Board, either through a conversion in accordance with applicable law, a merger with or into an existing corporation or otherwise in which all Units will be converted into or exchanged for shares of common stock of the resulting corporation. If the Company is unable to effectuate an Exchange Listing prior to the end of the term, the Company will use commercially reasonable efforts to wind down or liquidate pursuant to the procedures set forth in the LLC Agreement.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X, as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reported period. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2024. In the opinion of management, all adjustments which are of a normal recurring nature considered necessary for the fair presentation of consolidated financial statements have been included. The significant accounting policies consistently followed by the Company are: (a) Investment transactions are accounted for on the trade date; (b) In accordance with GAAP and the 1940 Act, the Company’s assets will generally be valued as follows: (i) securities or other instruments (other than as referred to in clauses (ii) and (iii) below) for which market quotes are readily available and deemed to represent fair value under GAAP will be valued based on quotes obtained from a quotation reporting system, market makers or pricing services (when deemed to represent fair value under GAAP); (ii) exchange-traded options, futures and options on futures will be valued at the settlement price determined by the exchange or through the use of a model such as Black-Scholes; (iii) short-term investments with maturities of sixty (60) days or less generally will be valued at amortized cost; and (iv) securities, loans or other instruments for which market quotes are not readily available or reliable under GAAP will be valued as described below: a. the quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of SLR responsible for the Portfolio Investment; b. preliminary valuation conclusions are then documented and discussed with senior management of the Adviser; c. the audit committee of the Board reviews the preliminary valuations of the Adviser and third-party valuation specialist, if any, that may from time to time be engaged by the Board, and responds to the valuation recommendations to reflect any comments; and d. the Board discusses valuations and determines the fair value of each investment in the Company’s portfolio in good faith based on the input of the Adviser, the audit committee, and third-party valuation specialist, if any. The valuation principles set forth above may be modified from time to time without notice to Unitholders, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule 2a-5 under the 1940 Act; and (6) maintain recordkeeping requirements under Rule 2a-5. When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Company will consider the pricing indicated by the external event to corroborate the valuation. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material. Investments in all asset classes will be valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the six months ended June 30, 2024, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process. ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy: Level 1 : Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date. Level 2 : Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices. Level 3 : Unobservable inputs for the asset or liability. In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience. (c) Gains or losses on investments are calculated by using the specific identification method. (d) The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring fee income as well as management fee and other fee income for services rendered, if any, are recorded as other income when earned. (e) The Company intends to comply with the applicable provisions of the Code pertaining to RICs to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4 % excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate. (f) Book and tax basis differences relating to Unitholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP. (g) Distributions to Unitholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. (h) In accordance with Regulation S-X and ASC Topic 810— Consolidation , the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies, if any. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company. (i) The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against the U.S. dollar on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. (j) In accordance with ASC 835-30, the Company reports origination and other expenses related to certain debt issuances, if any, as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method. (k) The Company records expenses related to applicable equity offering costs as a charge to capital upon the sale of units, in accordance with ASC 946-20-25. (l) Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when principal or interest cash payments are past due 30 days or more and/or when it is no longer probable that principal or interest cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment. (m) The Company records expenses directly related to its organization as incurred. (n) The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents. Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

Agreements and Related Party Tr

Agreements and Related Party Transactions	6 Months Ended
	Jun. 30, 2024
Agreement And Related Party Transactions [Abstract]
Agreements and Related Party Transactions	Note 3. Agreements and Related Party Transactions Pursuant to the Investment Management Agreement we have entered into with the Adviser, we intend to pay the Adviser certain management and incentive fees prior to and following an Exchange Listing. Prior to an Exchange Listing, the Adviser has been appointed to provide administrative and coordination services to the Company (in such capacity, the “Administrative Coordinator”). The Company will pay an administration fee to the Administrative Coordinator for such administrative and coordination services, each as defined and described further below. Following an Exchange Listing, we intend to enter into a separate administration agreement with an affiliate pursuant to which administrative services would be provided to the Company, as described further below. The cost of the base management fee, the incentive fee and the administration fee will ultimately be borne by our Unitholders. Management Fees The Company will pay the Adviser a management fee prior to an Exchange Listing (as the same may be adjusted pursuant to the LLC Agreement and the Investment Management Agreement, the “Pre-Exchange Listing Management Fee”) and a management fee following an Exchange Listing (as the same may be adjusted pursuant to the LLC Agreement and the Investment Management Agreement, the “Post-Exchange Listing Management Fee” and, together with the Pre-Exchange Listing Management Fee, the “Management Fee”). The Management Fee will be payable quarterly in arrears, as follows: • Pre-Exchange Listing . Prior to an Exchange Listing, the Pre-Exchange Listing Management Fee will be calculated as of the close of business on the last day of each calendar quarter in an amount equal to 1.50 % per annum of Invested Capital (defined as, as of any date, the sum of (i) capital contributions to the Company used to make Portfolio Investments and (ii) the total amount of credit drawn on subscription or similarly structured credit facilities). • Post-Exchange Listing . Following an Exchange Listing, the Post-Exchange Listing Management Fee will be an amount equal to 1.50 % per annum of the average value of the Company’s total assets at the end of the two most recently completed calendar quarters; provided, however, the Post-Exchange Listing Management Fee will be calculated at an annual rate of 1.00 % of the average value of the Company’s total assets at the end of the two most recently completed calendar quarters that exceeds the product of (i) 200 % and (ii) the value of the Company’s total net assets at the end of the immediately preceding calendar quarter. The Management Fee will be appropriately adjusted for any stub period. The Adviser may arrange for the Company to direct to a placement agent any portion of the Management Fee which the Adviser is owed for purposes of paying any placement fee that the Adviser owes to such placement agent. The Adviser will have the right, in its sole discretion, to waive or reduce, as well as recoup in a subsequent period, the Management Fee to which the Adviser is entitled in respect of all Unitholders’ Units in any particular calendar quarter. Any such Management Fee may be recouped by the Adviser in a future calendar quarter within three years of the date of the applicable waiver of the Management Fee and any such recoupment would be conditioned on the Company’s expense ratio at the time of recoupment, but after giving effect to the recoupment, being equal to or less than the expense ratio at the time of the waiver. The Adviser does not have a current intention to waive any Management Fees. Incentive Fee Distributions . Prior to an Exchange Listing, the Company will make distributions out of two categories: Current Proceeds and Disposition Proceeds (collectively referred to as “Investment Proceeds”). “Disposition Proceeds” means all amounts received by the Company upon the disposition of an investment, including full or partial repayments or amortization of principal (but excluding Current Proceeds). “Current Proceeds” means all proceeds from investments, including interest income, fee income, prepayment fees and exit fees, other than Disposition Proceeds, less Company expenses. The Adviser will apportion each Unitholder’s pro rata share of Investment Proceeds between Disposition Proceeds and Current Proceeds. Pre-Exchange Listing Incentive Fee . Prior to an Exchange Listing, and subject to availability, the Company will cause distributable cash to be distributed to Unitholders and to be paid to the Adviser as an incentive fee (the “Pre-Exchange Listing Incentive Fee”). Amounts of Investment Proceeds apportioned to Unitholders will be divided between and distributed to Unitholders, on the one hand, and the Adviser, on the other hand, in the following amounts and order of priority: (i) Disposition Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as a Pre-Exchange Listing Incentive Fee, on the other hand, in the following amounts and order of priority: (A) First, Return of Capital Contributions: 100 % to such Unitholder until such Unitholder has received cumulative distributions of Investment Proceeds pursuant to this clause (A) equal to such Unitholder’s total capital contributions to the Company (including amounts contributed to pay Pre-Exchange Listing Management Fees, Pre-Exchange Listing Administration Fees (defined below), Organizational Expenses (defined below) and other Company expenses); (B) Second, Unitholder Preferred Return: 100 % of all remaining Disposition Proceeds to Unitholders until they have each received cumulative distributions of Investment Proceeds, without duplication, pursuant to this clause (B) and clause (D) below and clause (ii)(A) and (ii)(C) below equal to 6 % per annum, compounded annually, on Unitholders’ capital contributions to the Company (including amounts contributed to pay Pre-Exchange Listing Management Fees, Pre-Exchange Listing Administration Fees, Organizational Expenses and other Company expenses), determined on the basis of all capital contributions made by such Unitholder and considering all distributions (including the subject distribution) under this “—Pre-Exchange Listing Incentive Fee” made to such Unitholder (computed from the dates that such capital contributions were due (or, if actually made later, the date on which such capital contributions were actually made) until the date that the Company, in its sole discretion, designates distributable cash as available for distribution or, if no such designation is made, the occurrence of an Event of Dissolution, as defined in the LLC Agreement) (the “Preferred Return”); (C) Third, Adviser Catch Up: 100 % of all remaining Disposition Proceeds to the Adviser as a Pre-Exchange Listing Incentive Fee, until the Adviser has received payments of Investment Proceeds with respect to Unitholders pursuant to this clause (C) and clause (ii)(B) below equal to 10 % of the total amounts due to Unitholders and earned by the Adviser pursuant to clause (B) above and this clause (C) and clause (ii)(A) and (ii)(B) below; and (D) Fourth, 90 %/ 10 %: 90 % of all remaining Disposition Proceeds to Unitholders and 10 % of all remaining Disposition Proceeds to the Adviser as a Pre-Exchange Listing Incentive Fee. In no event will the Adviser receive amounts of Pre-Exchange Listing Incentive Fees under clause (i)(C) and (i)(D) above in excess of the percentage of the Disposition Proceeds actually distributed to Unitholders pursuant to clause (i)(B), (i)(C) and (i)(D) above. In no event will the Adviser receive amounts attributable to Disposition Proceeds that, as of any distribution or payment date, exceed 20 % of cumulative realized capital gains net of all cumulative realized capital losses and unrealized capital depreciation. (ii) Current Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as a Pre-Exchange Listing Incentive Fee, on the other hand, in the following amounts and order of priority: (A) First, Unitholder Preferred Return: 100 % of all Current Proceeds to Unitholders until Unitholders have received cumulative distributions of Investment Proceeds, without duplication, pursuant to this clause (A) and clause (C) below and pursuant to clause (i)(B) and clause (i)(D) above equal to the Preferred Return; (B) Second, Adviser Catch Up: 100 % of all remaining Current Proceeds to the Adviser as a Pre-Exchange Listing Incentive Fee until the Adviser has received payments of Investment Proceeds with respect to Unitholders pursuant to this clause (B) and clause (i)(C) above equal to 10 % of the total amounts due to Unitholders and earned by the Adviser pursuant to clause (A) above and this clause (B) and pursuant to clause (i)(B) and clause (i)(C) above; and (C) Third, 90 %/ 10 %: 90 % of all remaining Current Proceeds to Unitholders and 10 % of all remaining Current Proceeds to the Adviser as a Pre-Exchange Listing Incentive Fee. In no event will the Adviser receive amounts of Pre-Exchange Listing Incentive Fees under clause (ii)(B) and (ii)(C) above in excess of the percentage of the Current Proceeds actually distributed to Unitholders pursuant to clause (ii)(A), (ii)(B) and (ii)(C) above. Post-Exchange Listing Incentive Fee . Following an Exchange Listing, the Company will pay an incentive fee to the Adviser consisting of two parts, as follows (the “Post-Exchange Listing Incentive Fee”) and, together with the Pre-Exchange Listing Incentive Fee, (the “Incentive Fee”): (i) Pre-Incentive Fee Net Investment Income. One part will be calculated and payable quarterly in arrears based on the net investment income for the immediately preceding calendar quarter. a. For this purpose, Pre-Incentive Fee Net Investment Income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued by the Company during the calendar quarter, minus the Company’s operating expenses for the quarter (including the Post-Exchange Listing Management Fees, expenses payable under an administration agreement, and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the Post-Exchange Listing Incentive Fee). b. Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Pre-Incentive Fee Net Investment Income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, will be compared to a “hurdle rate” of 1.75 % per quarter ( 7.00 % annualized). The Company’s Pre-Incentive Fee Net Investment Income used to calculate this part of the Post-Exchange Listing Incentive Fee is also included in the amount of its gross assets used to calculate the 1.50 % Post-Exchange Listing Management Fees. c. The Company will pay the Adviser a Post-Exchange Listing Incentive Fee with respect to the Company’s Pre-Incentive Fee Net Investment Income in each calendar quarter as follows: i. no Post-Exchange Listing Incentive Fee in any calendar quarter in which the Company’s Pre-Incentive Fee Net Investment Income does not exceed the quarterly hurdle rate of 1.75 %; ii. 100 % of the Company’s Pre-Incentive Fee Net Investment Income with respect to that portion of such Pre-Incentive Fee Net Investment Income, if any, that exceeds the hurdle rate but is less than 2.1875 % in any calendar quarter ( 8.75 % annualized); this portion of the Pre-Incentive Fee Net Investment Income (which exceeds the hurdle but is less than 2.1875 %) is referred to herein as the “catch-up.” The “catch-up” is meant to provide the Adviser with 20% of the Company’s Pre-Incentive Fee Net Investment Income as if a hurdle did not apply if this Pre-Incentive Fee Net Investment Income exceeds 2.1875 % in any calendar quarter; and iii. 20% of the amount of the Company’s Pre-Incentive Fee Net Investment Income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) payable to the Adviser (once the hurdle is reached and the catch-up is achieved, 20 % of all Pre-Incentive Fee Net Investment Income thereafter is allocated to the Adviser). These calculations will be appropriately pro-rated for any period of less than three months. Capital Gains Fee . The second part of the Post-Exchange Listing Incentive Fee, the “Capital Gains Fee”, will be determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Management Agreement as set forth below), commencing as of the end of the first fiscal year following an Exchange Listing, and will equal 20.0 % of the Company’s realized capital gains, if any, on a cumulative basis through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation as of each fiscal year end, less the amount of any previously paid capital gain Post-Exchange Listing Incentive Fees, with respect to the Company; provided that the Post-Exchange Listing Incentive Fee determined as of the end of the fiscal year in which an Exchange Listing is completed will be calculated for a period of shorter than twelve calendar months to take into account any realized capital gains computed net of all realized capital losses and unrealized capital depreciation. In the event that the Investment Management Agreement will terminate as of a date that is not a calendar year end, the termination date will be treated as though it were a calendar year end for purposes of calculating and paying a Capital Gains Fee. Administration Fees and Expenses Pre-Exchange Listing Administration Fees . The Company will pay SLR, in its capacity as the Administrative Coordinator, a fee (the “Pre-Exchange Listing Administration Fee”), calculated as of the close of business in New York, New York on the last day of each calendar quarter (the “Administration Fee Calculation Date”), in an amount equal to 0.08 % per annum of the average Cost Basis (defined as, as of any date, the aggregate accreted and amortized cost of all Portfolio Investments, including (i) any amounts reinvested in Portfolio Investments and (ii) the cost of Portfolio Investments acquired using leverage), as measured on the last day of the preceding quarter and the last day of the current quarter for the period ended and payable quarterly in arrears after such Administration Fee Calculation Date. The Pre-Exchange Listing Administration Fee will not offset any fees paid to the Adviser. The Administrative Coordinator will be responsible for all expenses of its own staff responsible for (i) certain on-going, routine, non-investment-related administrative services for the Company, (ii) the coordination of various third-party services needed or required by the Company and (iii) certain Unitholder servicing functions. The Pre-Exchange Listing Administration Fee will be appropriately adjusted for any stub period. The Administrative Coordinator will have the right, in its sole discretion, to waive, as well as recoup in a subsequent period, the Pre-Exchange Listing Administration Fee to which it is entitled in respect of all Unitholders’ Units in any particular calendar quarter. Any such Pre-Exchange Listing Administration Fee may be recouped by the Administrative Coordinator in a future calendar quarter within three years of the date of the applicable waiver of the Pre-Exchange Listing Administration Fee and any such recoupment would be conditioned on the Company’s expense ratio at the time of recoupment, but after giving effect to the recoupment, being equal to or less than the expense ratio at the time of the waiver. The Adviser does not have a current intention to waive any Pre-Exchange Listing Administrative Fee. Post-Exchange Listing Administration Expenses . In connection with an Exchange Listing, and subject to Board approval, the Company intends to enter into an administration agreement with SLR Capital Management, LLC (“SCM”) pursuant to which SCM will provide administrative services to the Company. For providing these services, facilities and personnel, the Company will reimburse SCM for the Company’s allocable portion of overhead and other expenses incurred by SCM in performing its obligations under the administration agreement (together with the Pre-Exchange Listing Administration Fee, the “Administration Expenses”). For the three and six months ended June 30, 2024, the Company incurred $ 106 and $ 201 , respectively, in Management Fees, $ 6 and $ 11 , respectively, in Administration Fees and $ 0 and $ 0 , respectively, in Incentive Fees. For the three months ended June 30, 2023 and the period January 18, 2023 (commencement of operations) to June 30, 2023, the Company incurred $ 11 and $ 11 , respectively, in Management Fees, $ 0 and $ 0 , respectively, in Administration Fees and $ 0 and $ 0 , respectively, in Incentive Fees. In addition, prior to an Exchange Listing, the aggregate amount of certain operating expenses relating to Unitholders investing directly in the Company will not exceed the following limits in any fiscal year: (A) if the Company has less than or equal to $ 400,000 in Commitments, an amount equal to the sum of (x) the product of the Commitments and 0.0025 and (y) $ 1,250 , or (B) if the Company has greater than $ 400,000 in Commitments, $ 2,250 (such figure, the “Operating Expense Cap”). Any amount in excess of the Operating Expense Cap for any fiscal year will be paid by the Adviser. For the avoidance of doubt, (i) the Operating Expense Cap will not apply to any fees, costs, expenses and liabilities allocable to persons investing indirectly in the Company through any Unitholder, (ii) the Company will not bear the costs of any third-party valuation agent engaged solely for purposes of valuing the Company’s Portfolio Investments at each quarter end and (iii) the Operating Expense Cap will no longer apply upon the effectuation of an Exchange Listing. The Adviser or Administrative Coordinator and/or their affiliates has advanced organizational and offering expenses to the Company, which include organizational fees, costs, expenses and liabilities of the Company, including legal expenses, incurred in connection with the initial offering of Units and the formation and establishment of the Company (the “Organizational Expenses”). The Adviser or Administrative Coordinator (or such affiliate) will be reimbursed by the Company for such advanced costs and expenses in an amount not to exceed $ 500 . The Company will be responsible for and pay (or reimburse) the Organizational Expenses subject to the cap described in the preceding sentence. Accordingly, in 2023, $ 76 of offering expenses were charged to capital and $ 131 of organizational costs were expensed.

Fair Value

Fair Value	6 Months Ended
	Jun. 30, 2024
Investments, Fair Value Disclosure [Abstract]
Fair Value	Note 4. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: Level 1. Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access. Level 2. Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: a) Quoted prices for similar assets or liabilities in active markets; b) Quoted prices for identical or similar assets or liabilities in non-active markets; c) Pricing models whose inputs are observable for substantially the full term of the asset or liability; and d) Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. Level 3. Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3). A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1. The following table presents the balances of assets measured at fair value on a recurring basis, as of June 30, 2024 and December 31, 2023: Fair Value Measurements As of June 30, 2024 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 34,886 $ 34,886 Warrants — — 3 3 Total Investments $ — $ — $ 34,889 $ 34,889 Fair Value Measurements As of December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 21,651 $ 21,651 Warrants — — 3 3 Total Investments $ — $ — $ 21,654 $ 21,654 While the Company has not made an election to apply the fair value option of accounting to any of its debt obligations, if the Company’s debt obligations were carried at fair value at June 30, 2024, the fair value of the SPV Facility and the Subscription Facility would be $ 8,200 and $ 13,100 , respectively. All debt obligations would be considered Level 3 liabilities and would be valued with market yield as the unobservable input. While the Company has not made an election to apply the fair value option of accounting to any of its debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2023, the fair value of the SPV Facility and the Subscription Facility would be $ 2,000 and $ 11,400 , respectively. All debt obligations would be considered Level 3 liabilities and would be valued with market yield as the unobservable input. The following tables provide a summary of the changes in fair value of Level 3 assets for the three and six months ended June 30, 2024, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at June 30, 2024: Bank Debt/Senior Warrants Total Fair value, March 31, 2024 $ 27,040 $ 3 $ 27,043 Total gains or losses included in earnings: Net realized loss — — — Net change in unrealized gain 100 — 100 Purchase of investment securities* 9,835 — 9,835 Proceeds from dispositions of investment securities ( 2,089 ) — ( 2,089 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, June 30, 2024 $ 34,886 $ 3 $ 34,889 Unrealized gains for the period relating to those Level 3 Net change in unrealized gain $ 100 $ — $ 100 Bank Debt/Senior Warrants Total Fair value, December 31, 2023 $ 21,651 $ 3 $ 21,654 Total gains or losses included in earnings: Net realized loss — — — Net change in unrealized gain 221 — 221 Purchase of investment securities* 16,604 — 16,604 Proceeds from dispositions of investment securities ( 3,590 ) — ( 3,590 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, June 30, 2024 $ 34,886 $ 3 $ 34,889 Unrealized gains for the period relating to those Level 3 Net change in unrealized gain $ 221 $ — $ 221 The following table provide a summary of the changes in fair value of Level 3 assets for the period January 18, 2023 (commencement of operations) to December 31, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2023: Bank Debt/Senior Warrants Total Fair value, January 18, 2023 $ — $ — $ — Total gains or losses included in earnings: Net realized loss — — — Net change in unrealized gain (loss) 94 — 94 Purchase of investment securities* 21,623 3 21,626 Proceeds from dispositions of investment securities ( 66 ) — ( 66 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, December 31, 2023 $ 21,651 $ 3 $ 21,654 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ 94 $ — $ 94 * Includes PIK capitalization and accretion of discount Quantitative Information about Level 3 Fair Value Measurements The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company. Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities. Quantitative information about the Company’s Level 3 asset fair value measurements as of June 30, 2024 and December 31, 2023 is summarized in the tables below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Bank Debt / Senior Secured Loans Asset $ 34,886 Income Approach Market Yield 11.1 % - 16.8 % 12.3 %) Warrants Asset $ 3 Market Approach Volatility 16.1 % - 16.1 % 16.1 %) Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Bank Debt / Senior Secured Loans Asset $ 21,651 Income Approach Market Yield 11.1 % - 17.6 % 12.5 %) Warrants Asset $ 3 Market Approach Volatility 18.9 % - 18.9 % 18.9 %) Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask spreads, if applicable, would result in a significantly lower or higher fair value measurement for such assets. Generally, an increase in market yields may result in a decrease in the fair value of certain of the Company’s investments. Weighted averages in the above tables are calculated based on fair value of the underlying assets.

Debt

Debt	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Debt	Note 5. Debt SPV Facility —On December 12, 2023, the Company, through its wholly-owned subsidiary, SLR Private Credit BDC II SPV LLC, entered into the $ 25,000 SPV Facility with Citibank, N.A. acting as administrative agent. The stated interest rate on the SPV Facility is Term SOFR plus 2.80 % with no SOFR floor requirement, and the final maturity date is December 12, 2028 . The fee on undrawn commitments is currently 0.50 %. The SPV Facility is secured by all of the assets held by the SPV. Under the terms of the SPV Facility, the Company and SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV also includes usual and customary events of default for credit facilities of this nature. As of June 30, 2024, there were $ 8,200 of borrowings outstanding under the SPV Facility. Subscription Facility —On March 20, 2023, the Company established the $ 25,000 Subscription Facility due March 20, 2025 with ING Capital LLC, as administrative agent and lender. The stated interest rate on the Subscription Facility is SOFR plus 2.75 - 3.00 %. Under the terms of the Subscription Facility, the Company has made certain customary representations and warranties, and is required to comply with various covenants, including reporting requirements and other customary requirements for similar credit facilities. The Subscription Facility also includes usual and customary events of default for credit facilities of this nature. As of June 30, 2024, there were $ 13,100 of borrowings outstanding under the Subscription Facility. The average annualized interest cost for borrowings for the six months ended June 30, 2024 and the period March 20, 2023 (commencement of the Subscription Facility) to December 31, 2023 was 8.31 % and 8.42 %, respectively. These costs are exclusive of other credit facility expenses such as unused fees. The maximum amount borrowed on the credit facilities during the six months ended June 30, 2024 and the period March 20, 2023 (commencement of the Subscription Facility) to December 31, 2023 was $ 23,000 and $ 13,400 , respectively.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6. Commitments and Contingencies The Company had unfunded debt commitments to various revolving and delayed-draw term loans. The total amount of these unfunded commitments as of June 30, 2024 and December 31, 2023 was $ 13,840 and $ 19,793 , respectively, comprised of the following: June 30, December 31, AMF Levered II, LLC $ 1,566 $ 3,133 Cerapedics, Inc. 1,489 1,489 Southern Orthodontics Partners Management, LLC 1,486 — OIS Management Services, LLC 1,163 1,362 AAH Topco, LLC 1,036 1,802 Human Interest, Inc. 1,032 1,032 Western Veterinary Partners LLC 1,007 — World Insurance Associates, LLC 852 852 Legacy Service Partners, LLC 787 1,237 CVAUSA Management, LLC 741 741 SPR Therapeutics, Inc. 499 — Quantcast Corporation 407 — West-NR Parent, Inc. 395 395 The Townsend Company, LLC 271 261 United Digestive MSO Parent, LLC 237 273 Vertos Medical, Inc. 198 198 Medrina, LLC 190 190 Crewline Buyer, Inc. 122 122 Exactcare Parent, Inc. 81 81 WCI-BXC Purchaser, LLC 77 77 Apex Service Partners, LLC 71 277 MRI Software LLC 67 67 UVP Management, LLC 66 174 Outset Medical, Inc. — 3,113 Retina Midco, Inc. — 769 Ardelyx, Inc. — 750 Alkeme Intermediary Holdings, LLC — 668 Peter C. Foy & Associates Insurance Services, LLC — 378 Toptal, LLC — 352 Total Commitments $ 13,840 $ 19,793 The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of June 30, 2024 and December 31, 2023, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment. In the normal course of our business, we invest or trade in various financial instruments and may enter into various investment activities with off-balance sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of off-balance sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statement of Assets and Liabilities. As of June 30, 2024, we held no such contracts. From time to time, the Company may become a party to certain legal proceedings incidental to the normal course of its business. As of June 30, 2024 and December 31, 2023, management is not aware of any material pending or threatened litigation that would require accounting recognition or financial statement disclosure.

Unitholders' Capital

Unitholders' Capital	6 Months Ended
	Jun. 30, 2024
Limited Liability Company (LLC) Members' Equity [Abstract]
Unitholders' capital	Note 7. Unitholders’ Capital Transactions in Unitholders’ capital were as follows: Three months ended Three months ended Units at beginning of period 647,099 120,000 Units issued 254,939 — Units issued and outstanding at end of period 902,038 120,000 Six months ended For the Units at beginning of period 551,497 — Units issued 350,541 120,040 Units canceled — ( 40 ) Units issued and outstanding at end of period 902,038 120,000 * Commencement of operations

Financial Highlights

Financial Highlights	6 Months Ended
	Jun. 30, 2024
Investment Company, Financial Highlights [Abstract]
Financial Highlights	Note 8. Financial Highlights The following is a schedule of financial highlights for the six months ended June 30, 2024 and for the period January 18, 2023 (commencement of operations) to June 30, 2023: Six months ended For the period Per Share Data: (a) Net asset value per Unit, beginning of period $ 15.66 $ — Net investment income (loss) 0.48 ( 5.68 ) Net realized and unrealized gain (loss) 0.25 ** ( 0.01 ) Net increase (decrease) in Unitholders’ capital resulting from operations 0.73 ( 5.69 ) Distributions to Unitholders: From distributable earnings ( 0.45 ) — Issuance of Units — 25.00 Offering costs — ( 0.61 ) Net asset value per Unit, end of period $ 15.94 $ 18.70 Total Return (b)(c) 4.66 % ( 25.24 %) Unitholders’ capital, end of period $ 14,375 $ 2,244 Units outstanding, end of period 902,038 120,000 Ratios to average net assets of Unitholders’ Capital (c): Net investment income (loss) 3.04 % ( 26.11 %) Operating expenses 5.16 % 21.83 % Interest and other credit facility expenses 10.52 % 5.92 % Total expenses 15.68 % 27.75 % Average debt outstanding $ 18,426 $ 182 Portfolio turnover ratio 13.0 % 0.2 % (a) Calculated using the average Units outstanding method. Weighted average Units outstanding for the six months ended June 30, 2024 and for the period March 31, 2023 (date of first sale of Units to Unitholders) through June 30, 2023 were 655,329 and 120,000 , respectively. (b) Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load. The beginning NAV per Unit was determined to be as of the date of the first sale of Units to Unitholders as management considers this to be the most meaningful disclosure for investors. (c) Not annualized for periods less than one year. Average net assets are calculated for the six months ended June 30, 2024 and for the period March 31, 2023 (date of first sale of Units to Unitholders) through June 30, 2023. * Commencement of operations ** Includes the impact of the different Unit amounts used in calculating per Unit data as a result of calculating certain per Unit data based upon the weighted average Units outstanding during the period and certain per Unit data based on the Units outstanding as of a period end.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 9. Subsequent Events The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued. There have been no subsequent events that require recognition or disclosure in these consolidated financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

Fair Value (Tables)

Fair Value (Tables)	6 Months Ended
	Jun. 30, 2024
Investments, Fair Value Disclosure [Abstract]
Summary of the Balances of Assets Measured at Fair Value	The following table presents the balances of assets measured at fair value on a recurring basis, as of June 30, 2024 and December 31, 2023: Fair Value Measurements As of June 30, 2024 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 34,886 $ 34,886 Warrants — — 3 3 Total Investments $ — $ — $ 34,889 $ 34,889 Fair Value Measurements As of December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 21,651 $ 21,651 Warrants — — 3 3 Total Investments $ — $ — $ 21,654 $ 21,654
Summary of the Changes in Fair Value of Level 3 Assets	The following tables provide a summary of the changes in fair value of Level 3 assets for the three and six months ended June 30, 2024, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at June 30, 2024: Bank Debt/Senior Warrants Total Fair value, March 31, 2024 $ 27,040 $ 3 $ 27,043 Total gains or losses included in earnings: Net realized loss — — — Net change in unrealized gain 100 — 100 Purchase of investment securities* 9,835 — 9,835 Proceeds from dispositions of investment securities ( 2,089 ) — ( 2,089 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, June 30, 2024 $ 34,886 $ 3 $ 34,889 Unrealized gains for the period relating to those Level 3 Net change in unrealized gain $ 100 $ — $ 100 Bank Debt/Senior Warrants Total Fair value, December 31, 2023 $ 21,651 $ 3 $ 21,654 Total gains or losses included in earnings: Net realized loss — — — Net change in unrealized gain 221 — 221 Purchase of investment securities* 16,604 — 16,604 Proceeds from dispositions of investment securities ( 3,590 ) — ( 3,590 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, June 30, 2024 $ 34,886 $ 3 $ 34,889 Unrealized gains for the period relating to those Level 3 Net change in unrealized gain $ 221 $ — $ 221 The following table provide a summary of the changes in fair value of Level 3 assets for the period January 18, 2023 (commencement of operations) to December 31, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2023: Bank Debt/Senior Warrants Total Fair value, January 18, 2023 $ — $ — $ — Total gains or losses included in earnings: Net realized loss — — — Net change in unrealized gain (loss) 94 — 94 Purchase of investment securities* 21,623 3 21,626 Proceeds from dispositions of investment securities ( 66 ) — ( 66 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, December 31, 2023 $ 21,651 $ 3 $ 21,654 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ 94 $ — $ 94 * Includes PIK capitalization and accretion of discount
Summary of Quantitative Information about the Company's Level 3 Asset Fair Value Measurements	Quantitative information about the Company’s Level 3 asset fair value measurements as of June 30, 2024 and December 31, 2023 is summarized in the tables below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Bank Debt / Senior Secured Loans Asset $ 34,886 Income Approach Market Yield 11.1 % - 16.8 % 12.3 %) Warrants Asset $ 3 Market Approach Volatility 16.1 % - 16.1 % 16.1 %) Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Bank Debt / Senior Secured Loans Asset $ 21,651 Income Approach Market Yield 11.1 % - 17.6 % 12.5 %) Warrants Asset $ 3 Market Approach Volatility 18.9 % - 18.9 % 18.9 %)

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Summary Of Unfunded Debt Commitments	June 30, December 31, AMF Levered II, LLC $ 1,566 $ 3,133 Cerapedics, Inc. 1,489 1,489 Southern Orthodontics Partners Management, LLC 1,486 — OIS Management Services, LLC 1,163 1,362 AAH Topco, LLC 1,036 1,802 Human Interest, Inc. 1,032 1,032 Western Veterinary Partners LLC 1,007 — World Insurance Associates, LLC 852 852 Legacy Service Partners, LLC 787 1,237 CVAUSA Management, LLC 741 741 SPR Therapeutics, Inc. 499 — Quantcast Corporation 407 — West-NR Parent, Inc. 395 395 The Townsend Company, LLC 271 261 United Digestive MSO Parent, LLC 237 273 Vertos Medical, Inc. 198 198 Medrina, LLC 190 190 Crewline Buyer, Inc. 122 122 Exactcare Parent, Inc. 81 81 WCI-BXC Purchaser, LLC 77 77 Apex Service Partners, LLC 71 277 MRI Software LLC 67 67 UVP Management, LLC 66 174 Outset Medical, Inc. — 3,113 Retina Midco, Inc. — 769 Ardelyx, Inc. — 750 Alkeme Intermediary Holdings, LLC — 668 Peter C. Foy & Associates Insurance Services, LLC — 378 Toptal, LLC — 352 Total Commitments $ 13,840 $ 19,793

Unitholders' Capital (Tables)

Unitholders' Capital (Tables)	6 Months Ended
	Jun. 30, 2024
Limited Liability Company (LLC) Members' Equity [Abstract]
Summary Of Transactions In Unitholders Capital	Transactions in Unitholders’ capital were as follows: Three months ended Three months ended Units at beginning of period 647,099 120,000 Units issued 254,939 — Units issued and outstanding at end of period 902,038 120,000 Six months ended For the Units at beginning of period 551,497 — Units issued 350,541 120,040 Units canceled — ( 40 ) Units issued and outstanding at end of period 902,038 120,000 * Commencement of operations

Financial Highlights (Tables)

Financial Highlights (Tables)	6 Months Ended
	Jun. 30, 2024
Investment Company, Financial Highlights [Abstract]
Summary of Financial Highlights	The following is a schedule of financial highlights for the six months ended June 30, 2024 and for the period January 18, 2023 (commencement of operations) to June 30, 2023: Six months ended For the period Per Share Data: (a) Net asset value per Unit, beginning of period $ 15.66 $ — Net investment income (loss) 0.48 ( 5.68 ) Net realized and unrealized gain (loss) 0.25 ** ( 0.01 ) Net increase (decrease) in Unitholders’ capital resulting from operations 0.73 ( 5.69 ) Distributions to Unitholders: From distributable earnings ( 0.45 ) — Issuance of Units — 25.00 Offering costs — ( 0.61 ) Net asset value per Unit, end of period $ 15.94 $ 18.70 Total Return (b)(c) 4.66 % ( 25.24 %) Unitholders’ capital, end of period $ 14,375 $ 2,244 Units outstanding, end of period 902,038 120,000 Ratios to average net assets of Unitholders’ Capital (c): Net investment income (loss) 3.04 % ( 26.11 %) Operating expenses 5.16 % 21.83 % Interest and other credit facility expenses 10.52 % 5.92 % Total expenses 15.68 % 27.75 % Average debt outstanding $ 18,426 $ 182 Portfolio turnover ratio 13.0 % 0.2 % (a) Calculated using the average Units outstanding method. Weighted average Units outstanding for the six months ended June 30, 2024 and for the period March 31, 2023 (date of first sale of Units to Unitholders) through June 30, 2023 were 655,329 and 120,000 , respectively. (b) Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load. The beginning NAV per Unit was determined to be as of the date of the first sale of Units to Unitholders as management considers this to be the most meaningful disclosure for investors. (c) Not annualized for periods less than one year. Average net assets are calculated for the six months ended June 30, 2024 and for the period March 31, 2023 (date of first sale of Units to Unitholders) through June 30, 2023. * Commencement of operations ** Includes the impact of the different Unit amounts used in calculating per Unit data as a result of calculating certain per Unit data based upon the weighted average Units outstanding during the period and certain per Unit data based on the Units outstanding as of a period end.

Organization - Additional Infor

Organization - Additional Information (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($) $ / shares
Nature Of Operations [Line Items]
Date of incorporation	Apr. 18, 2022
Investment company capital commitement	$ 66,780
Stock issued during the period net of shares repurchased and cancelled value	$ 3,000
Common units issued price per share | $ / shares	$ 25
Capital commitments drawn	$ 15,400
Undrawn capital commitment	$ 51,380
Offering period for offer of shares to the investors	18 months
Time gap between the date of issuance of units and the funding date	10 days
Threshold minimum net assets of the acquire post acquisition to be maintained	$ 1,000,000
Maximum
Nature Of Operations [Line Items]
Investment company capital commitement	400,000
Estimated earnings before interest tax depreciation and amortization of the borrower	250,000
Minimum
Nature Of Operations [Line Items]
Investment company capital commitement	400,000
Estimated earnings before interest tax depreciation and amortization of the borrower	$ 25,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Excise tax rate applicable on taxable income In excess of distributions	4%
Number of days for either the principal or interest to be overdue for investments to be classified under non accrual	30 days

Agreements and Related Party _2

Agreements and Related Party Transactions - Additional Information (Details) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended	11 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) Product	Dec. 31, 2023 USD ($)
Agreement And Related Party Transactions [Line Items]
Preexchange listing fees as a percentage of invested capital on the last day of each calendar quarter	1.50%			1.50%
Post exchange listing management fees as a percentage of average value of companies total assets based on the recently completed two calendar quarters	1.50%			1.50%
Post Exchange Listing Management Fees Base Percentage Of Average Value Of Companies Total Assets Based On The Recently Completed Two Calendar Quarters	1%			1%
Factor for calculating the post exchange listing management fees	200%			200%
Return of capital contributions as percentage of proceeds received from the investor including amount contributed towards fees	100%			100%
Return of capital contributions as a percentage of proceeds received from the investor including amount contributed towards fees to preferred unit holders	100%			100%
Return of capital contribution compound interest payable percentage	6%			6%
Percentage of the remaining amount after distribution to unit holders payable to advisors towards pre exchange listing incentive fees	100%			100%
Percentage of distribution to unit holders payable as advisor fees at the time of disposition	10%			10%
Percentage of remaining proceeds to unit holders payable after distribution to unit holder preferred unit holders and administration fees	90%			90%
Percentage of all remaining disposition proceeds payable to advisor towards preexchange listing incentive fees	10%			10%
Advisor fees as a percentage of cumulative realized capital gains net of all cumulative realized capitai losses and capital depreciation percentage	20%			20%
Percentage of current distributions payable to unit holders	100%			100%
Remaining current proceeds payable to advisors towards percentage	100%			100%
Remaining current proceeds payable to advisors towards fees as percentage of total amount due to unit holders	10%			10%
Percentage remaining after distribution of current proceeds payable to unit holders	90%			90%
Percentage remaining after distribution of current proceeds payable to advisors towards fees	10%			10%
Preincentive fee net investment income hurdle rate percentage per quarter	1.75%			1.75%
Preincentive fee net investment income hurdle rate percentage per annum	7%			7%
Post exchange listing management fees percentage	1.50%			1.50%
Post exchange listing fees admissible if the preincentive fee net investment income does not exceed the threshold rate percentage				0%
Percentage of preincentive fee net income that exceeds the hurdle rate one				100%
Preincentive fee net investment income hurdle rate percentage per quarter two				2.1875%
Preincentive fee net investment income hurdle rate percentage per annum Two				8.75%
Percentage of preincentive fee net income in excess of hurdle rate two towards advisor fees				2.1875%
Percentage of preincentive fee net investment towards advisory fees once the hurdle rate is reached in its entirety	20%			20%
Pre exchange listing administration fees as a percentage of the average investments for the current and the preceeding quarter				0.08%
Investment company comitted capital				$ 66,780
Factor for calculating the lower limit in respect of operating expenses relating to unit holders | Product				0.0025
Monetary factor for calculating the lower limit in respect of operating expenses relating to unit holders				$ 1,250
Operating expenses relating to unit holders maximum limit				2,250
Reimbursement towards administration expenses threshold limit maximum				500
Investment company offering costs incurred value	$ 0	$ 1	$ 74	0	$ 76
Organizational expenses	$ 0	15	131	$ 0	$ 131
Percentage of capital gains fee payable on capital gains	20%			20%
Maximum
Agreement And Related Party Transactions [Line Items]
Investment company comitted capital				$ 400,000
Minimum
Agreement And Related Party Transactions [Line Items]
Investment company comitted capital				400,000
Post Exchange Listing Administration Expenses | SLR Capital Management LLC
Agreement And Related Party Transactions [Line Items]
Management fees	$ 106	11	11	201
Administration fees	6	0	0	11
Incentive fee expenses	$ 0	$ 0	$ 0	$ 0

Fair Value - Summary of the Bal

Fair Value - Summary of the Balances of Assets Measured at Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	$ 34,889	$ 21,654
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	0	0
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	0	0
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	34,889	21,654
Bank Debt And Senior Secured Loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	34,886	21,651
Bank Debt And Senior Secured Loans | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	0	0
Bank Debt And Senior Secured Loans | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	0	0
Bank Debt And Senior Secured Loans | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	34,886	21,651
Warrant
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	3	3
Warrant | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	0	0
Warrant | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	0	0
Warrant | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, fair value disclosure	$ 3	$ 3

Fair Value - Summary of the Cha

Fair Value - Summary of the Changes in Fair Value of Level 3 Assets (Details) - USD ($) $ in Thousands		3 Months Ended		5 Months Ended	6 Months Ended	11 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2024	Dec. 31, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		$ 27,043		$ 0	$ 21,654	$ 0
Total gains or losses included in earnings:
Net realized gain (loss)		0				0
Net change in unrealized gain (loss)		100	$ (1)	(1)	221	94
Purchase of investment securities	[1]	9,835			16,604	21,626
Proceeds from dispositions of investment securities		(2,089)			(3,590)	(66)
Transfers into Level 3		0			0	0
Transfers out of Level 3		0			0	0
Ending balance		$ 34,889			$ 34,889	$ 21,654
Unrealized gains for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]		Net change in unrealized gain (loss)			Net change in unrealized gain (loss)	Net change in unrealized gain (loss)
Net change in unrealized gain (loss)		$ 100			$ 221	$ 94
Bank Debt And Senior Secured Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		27,040		0	21,651	0
Total gains or losses included in earnings:
Net realized gain (loss)		0			0	0
Net change in unrealized gain (loss)		100			221	94
Purchase of investment securities	[1]	9,835			16,604	21,623
Proceeds from dispositions of investment securities		(2,089)			(3,590)	(66)
Transfers into Level 3		0			0	0
Transfers out of Level 3		0			0	0
Ending balance		34,886			34,886	21,651
Unrealized gains for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
Net change in unrealized gain (loss)		100			221	94
Warrant
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		3		$ 0	3	0
Total gains or losses included in earnings:
Net realized gain (loss)		0			0	0
Net change in unrealized gain (loss)					0	0
Purchase of investment securities	[1]				0	3
Proceeds from dispositions of investment securities					0	0
Transfers into Level 3		0			0	0
Transfers out of Level 3		0			0	0
Ending balance		3			3	3
Unrealized gains for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
Net change in unrealized gain (loss)		$ 0			$ 0	$ 0
[1] * Includes PIK capitalization and accretion of discount

Fair Value - Summary of Quantit

Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset Fair Value Measurements (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, fair value disclosure	$ 34,889	$ 21,654
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, fair value disclosure	34,889	21,654
Bank Debt And Senior Secured Loans | Market Yield | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, fair value disclosure	$ 34,886	$ 21,651
Principal Valuation Technique/Methodology	Income Approach	Income Approach
Unobservable Input	Market Yield	Market Yield
Maximum | Bank Debt And Senior Secured Loans | Market Yield | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range (Weighted Average)	16.80%	17.60%
Minimum | Bank Debt And Senior Secured Loans | Market Yield | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range (Weighted Average)	11.10%	11.10%
Weighted Average | Bank Debt And Senior Secured Loans | Market Yield | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range (Weighted Average)	12.30%	12.50%
Warrant
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, fair value disclosure	$ 3	$ 3
Warrant | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, fair value disclosure	3	3
Warrant | Market Yield | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, fair value disclosure	$ 3	$ 3
Principal Valuation Technique/Methodology	Market Approach	Market Approach
Unobservable Input	Volatility	Volatility
Warrant | Maximum | Market Yield | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range (Weighted Average)	16.10%	18.90%
Warrant | Minimum | Market Yield | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range (Weighted Average)	16.10%	18.90%
Warrant | Weighted Average | Market Yield | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range (Weighted Average)	16.10%	18.90%

Fair Value - Additional Informa

Fair Value - Additional Information (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Subscription Facility
Fair Value, Option, Quantitative Disclosures [Line Items]
Debt Instrument, Fair Value Disclosure	$ 13,100	$ 11,400
SPV Facility [Member]
Fair Value, Option, Quantitative Disclosures [Line Items]
Debt Instrument, Fair Value Disclosure	$ 8,200	$ 2,000

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($) $ in Thousands			3 Months Ended	6 Months Ended	9 Months Ended
	Dec. 12, 2023	Mar. 20, 2023	Mar. 31, 2024	Jun. 30, 2024	Dec. 31, 2023
Line of Credit Facility [Line Items]
Line of credit outstanding amount				$ 8,200
Subscription Facility
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity		$ 25,000
Line of credit outstanding amount			$ 13,100
Long-term line of credit				12,905	$ 11,080
Line of credit facility, interest rate during period			8.31%		8.42%
Line of credit facility, maximum amount outstanding during period				23,000	$ 13,400
Subscription Facility | Maximum
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		3%
Subscription Facility | Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		2.75%
SPV Facility
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity	$ 25,000
Debt Instrument, Maturity Date	Dec. 12, 2028
Fee on undrawn commitments	0.50%
Long-term line of credit				$ 7,807	$ 1,654
SPV Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	2.80%

Commitments and Contingencies -

Commitments and Contingencies - Summary Of Unfunded Debt Commitments (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Other Commitments [Line Items]
Unfunded commitments	$ 13,840	$ 19,793
Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	13,840	19,793
AMF Levered II, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	1,566	3,133
Cerapedics, Inc. | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	1,489	1,489
Southern Orthodontics Partners Management, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	1,486	0
OIS Management Services, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	1,163	1,362
AAH Topco, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	1,036	1,802
Human Interest, Inc. | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	1,032	1,032
Western Veterinary Partners LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	1,007	0
World Insurance Associates, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	852	852
Legacy Service Partners, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	787	1,237
CVAUSA Management LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	741	741
SPR Therapeutics, Inc. | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	499	0
Quantcast Corporation | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	407	0
West-NR Parent, Inc. | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	395	395
The Townsend Company, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	271	261
United Digestive MSO Parent LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	237	273
Vertos Medical Inc | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	198	198
Medrina, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	190	190
Crewline Buyer, Inc. | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	122	122
Exactcare Parent, Inc. | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	81	81
WCI-BXC Purchaser, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	77	77
Apex Service Partners, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	71	277
MRI Software LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	67	67
UVP Management, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	66	174
Outset Medical, Inc. | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	0	3,113
Retina Midco, Inc. | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	0	769
Ardelyx, Inc. | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	0	750
Alkeme Intermediary Holdings, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	0	668
Peter C. Foy & Associates Insurance Services, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	0	378
Toptal, LLC | Unfunded Debt And Equity Commitments
Other Commitments [Line Items]
Unfunded commitments	$ 0	$ 352

Commitments and Contingencies_2

Commitments and Contingencies - Additional information (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Other Commitments [Abstract]
Unfunded commitments	$ 13,840	$ 19,793

Unitholders' Capital - Summary

Unitholders' Capital - Summary Of Transactions In Unitholders Capital (Details) - shares	3 Months Ended		5 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2024
Limited Liability Company (LLC) Members' Equity [Abstract]
Units at beginning of period	647,099	120,000	0	551,497
Units issued	254,939	0	120,040	350,541
Units canceled	0	0	(40)	0
Units issued and outstanding at end of period	902,038	120,000	120,000	902,038

Financial Highlights - Summary

Financial Highlights - Summary of Financial Highlights (Details) - USD ($) $ / shares in Units, $ in Thousands	5 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Jan. 17, 2023
Per Share Data:
Net asset value per Unit, beginning of period	$ 0	$ 15.66
Net investment income (loss)	(5.68)	0.48
Net realized and unrealized gain (loss)	(0.01)	0.25
Net increase (decrease) in Unitholders' capital resulting from operations	(5.69)	0.73
Distributions To Unitholders [Abstract]
From distributable earnings	0	(0.45)
Issuance of Units	25	0
Offering costs	(0.61)	0
Net asset value per Unit, end of period	$ 18.7	$ 15.94
Total Return	(25.24%)	4.66%
Unitholders' capital, end of period	$ 2,244	$ 14,375		$ 8,635
Units outstanding, end of period	120,000	902,038	647,099	551,497	120,000	0
Ratios to average net assets of Unitholders' Capital:
Net investment income (loss)	(26.11%)	3.04%
Operating expenses	21.83%	5.16%
Interest and other credit facility expenses	5.92%	10.52%
Total expenses	27.75%	15.68%
Average debt outstanding	$ 182	$ 18,426
Portfolio turnover ratio	0.20%	13%

Financial Highlights - Summar_2

Financial Highlights - Summary of Financial Highlights (Parenthetical) (Details) - shares	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023	Mar. 31, 2023	Jan. 17, 2023
Investment Company, Financial Highlights [Line Items]
Common Unit, Outstanding	902,038	647,099	551,497	120,000	120,000	0
Weighted Average
Investment Company, Financial Highlights [Line Items]
Common Unit, Outstanding	655,329			120,000

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - shares	3 Months Ended		5 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2024
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues	254,939	0	120,040	350,541